Scholar Rock Holding Corp. (SRRK)
44.27
-0.57
(-1.27%)
USD |
NASDAQ |
Feb 27, 16:00
44.33
+0.06
(+0.14%)
After-Hours: 20:00
Scholar Rock Research and Development Expense (TTM) : 210.30M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Krystal Biotech, Inc. | 55.08M |
| Stoke Therapeutics, Inc. | 117.76M |
| Zymeworks, Inc. | 142.83M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |